79 related articles for article (PubMed ID: 8938186)
1. Effects of varying doses of spironolactone without and with nitrates on portal vein pressure and kidney function in partial portal vein ligated rats.
Van de Casteele M; Van Roey G; Nevens F; Fevery J
Hepatology; 1996 Dec; 24(6):1492-6. PubMed ID: 8938186
[TBL] [Abstract][Full Text] [Related]
2. Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis.
Bellis L; Berzigotti A; Abraldes JG; Moitinho E; García-Pagán JC; Bosch J; Rodés J
Hepatology; 2003 Feb; 37(2):378-84. PubMed ID: 12540788
[TBL] [Abstract][Full Text] [Related]
3. Differing actions of the acute administration of propranolol and isosorbide-5-mononitrate on the portal circulation.
Forrest EH; Jalan R; Redhead DN; Hayes PC
Aliment Pharmacol Ther; 1996 Oct; 10(5):795-800. PubMed ID: 8899089
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a single oral dose of isorsorbide 5-mononitrate in normal dogs and in dogs with congestive heart failure.
Adin DB; Kittleson MD; Hornof WJ; Kass PH
J Vet Intern Med; 2001; 15(2):105-11. PubMed ID: 11300592
[TBL] [Abstract][Full Text] [Related]
5. Long-term administration of isosorbide-5-mononitrate does not impair renal function in cirrhotic patients.
Salerno F; Borroni G; Lorenzano E; Solenghi D; Cazzaniga M; Bissoli F; Ceriani R; deFranchis R
Hepatology; 1996 May; 23(5):1135-40. PubMed ID: 8621145
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate.
Pipili-Synetos E; Papageorgiou A; Sakkoula E; Sotiropoulou G; Fotsis T; Karakiulakis G; Maragoudakis ME
Br J Pharmacol; 1995 Sep; 116(2):1829-34. PubMed ID: 8528567
[TBL] [Abstract][Full Text] [Related]
7. Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension.
Albillos A; García-Pagán JC; Iborra J; Bandi JC; Cacho G; Pérez-Paramo M; Escorsell A; Calleja JL; Escartín P; Bosch J
Gastroenterology; 1998 Jul; 115(1):116-23. PubMed ID: 9649466
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term octreotide and isosorbide dinitrate on haemodynamics in rats with portal vein stenosis.
Lin HC; Huang YT; Cheng YR; Hou MC; Lee FY; Chang FY; Tsai YT; Lee SD
Clin Sci (Lond); 1998 Jun; 94(6):645-50. PubMed ID: 9854463
[TBL] [Abstract][Full Text] [Related]
9. Vascular hyporeactivity persists despite increased contractility after long-term administration of isosorbide dinitrate in portal hypertensive rats.
Huang YT; Lin HC; Tsai JF; Hou MC; Lee SD; Hong CY
J Hepatol; 1998 Jun; 28(6):1037-44. PubMed ID: 9672181
[TBL] [Abstract][Full Text] [Related]
10. Modulation of hepatic perfusion did not improve recovery from hepatic outflow obstruction.
Arlt J; Wei W; Xie C; Homeyer A; Settmacher U; Dahmen U; Dirsch O
BMC Pharmacol Toxicol; 2017 Jun; 18(1):50. PubMed ID: 28651622
[TBL] [Abstract][Full Text] [Related]
11. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB
Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789
[TBL] [Abstract][Full Text] [Related]
12. Acute effect of propranolol and isosorbide-5-mononitrate administration on renal blood flow in cirrhotic patients.
Stanley AJ; Bouchier IA; Hayes PC
Gut; 1998 Feb; 42(2):283-7. PubMed ID: 9536956
[TBL] [Abstract][Full Text] [Related]
13. Tolerance to nitroglycerin induced by isosorbide-5-mononitrate infusion in vivo.
Manabe T; Yamamoto A; Satoh K; Ichihara K
Biol Pharm Bull; 2001 Dec; 24(12):1370-2. PubMed ID: 11767104
[TBL] [Abstract][Full Text] [Related]
14. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
[TBL] [Abstract][Full Text] [Related]
15. Dose dependence of tolerance during treatment with mononitrates.
Tauchert M; Jansen W; Osterspey A; Fuchs M; Hombach V; Hilger HH
Z Kardiol; 1983; 72 Suppl 3():218-28. PubMed ID: 6666225
[TBL] [Abstract][Full Text] [Related]
16. Reduction of portal pressure by chronic administration of isosorbide dinitrate in patients with cirrhosis: effects on systemic and splanchnic hemodynamics and liver function.
Ikegami M; Toyonaga A; Tanikawa K
Am J Gastroenterol; 1992 Sep; 87(9):1160-4. PubMed ID: 1519573
[TBL] [Abstract][Full Text] [Related]
17. [Intracoronary isosorbide mononitrate versus placebo. A double-blind study with quantitative coronary angiography].
Vieira Botelho R; Feres F; São Thiago LE; Abud R; Carneiro JK; Pinto I; Rego Sousa AG; Rego Sousa JE
Arq Bras Cardiol; 1995 Oct; 65(4):313-5. PubMed ID: 8728803
[TBL] [Abstract][Full Text] [Related]
18. Reduced liver function is the trigger for renal sodium retention following portal vein ligation in the rat.
Murakami S; Ohno T; Bernardo JF; Pfeifer CA; Li T; Zhang Y; Dubey RK; Branch RA; Sabra R
J Gastroenterol Hepatol; 1996 Sep; 11(9):850-6. PubMed ID: 8889965
[TBL] [Abstract][Full Text] [Related]
19. Re-evaluation of the role of aldosterone in mechanism of natriuresis induced by extracellular fluid volume expansion.
Turek R; Ponec J; Brlicová A; Lichardus B
Endocrinol Exp; 1976; 10(4):253-7. PubMed ID: 1087225
[TBL] [Abstract][Full Text] [Related]
20. [5-isosorbide mononitrate at rest and on exercise in coronary heart disease: acute and long-term effect].
Jansen W; Osterspey A; Tauchert M; Schmid G; Schell U; Fuchs M; Hombach V; Hilger HH
Dtsch Med Wochenschr; 1982 Oct; 107(40):1499-506. PubMed ID: 7117166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
